Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships.

Mitochondrial fatty acid oxidation deficiencies are due to genetic defects in enzymes of fatty acid beta-oxidation and transport proteins. Genetic defects have been identified in most of the genes where nearly all types of sequence variations (mutation types) have been associated with disease. In this paper, we will discuss the effects of the various types of sequence variations encountered and review current knowledge regarding the genotype-phenotype relationship, especially in patients with acyl-CoA dehydrogenase deficiencies where sufficient material exists for a meaningful discussion. Because mis-sense sequence variations are prevalent in these diseases, we will discuss the implications of these types of sequence variations on the processing and folding of mis-sense variant proteins. As the prevalent mis-sense variant K304E MCAD protein has been studied intensively, the investigations on biogenesis, stability and kinetic properties for this variant enzyme will be discussed in detail and used as a paradigm for the study of other mis-sense variant proteins. We conclude that the total effect of mis-sense sequence variations may comprise an invariable--sequence variation specific--effect on the catalytic parameters and a conditional effect, which is dependent on cellular, physiological and genetic factors other than the sequence variation itself.

[1]  D. Cooper,et al.  Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic disease , 2002, Human mutation.

[2]  S. Eaton,et al.  Mammalian mitochondrial beta-oxidation. , 1996, The Biochemical journal.

[3]  J. Vockley,et al.  Purification and characterization of two polymorphic variants of short chain acyl-CoA dehydrogenase reveal reduction of catalytic activity and stability of the Gly185Ser enzyme. , 2002, Biochemistry.

[4]  S. Dimauro,et al.  Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria , 1973, Science.

[5]  A. Fersht,et al.  Protein Folding and Unfolding at Atomic Resolution , 2002, Cell.

[6]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[7]  N. Blau,et al.  Tetrahydrobiopterin Responsiveness in Phenylketonuria. Two New Cases and a Review of Molecular Genetic Findings , 2002, Journal of Inherited Metabolic Disease.

[8]  C. Stanley,et al.  Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. , 1992, The New England journal of medicine.

[9]  Piero Rinaldo,et al.  Fatty acid oxidation disorders. , 2002, Annual review of physiology.

[10]  N. Gregersen,et al.  Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[11]  D. Rabier,et al.  Defects in activation and transport of fatty acids , 1999, Journal of Inherited Metabolic Disease.

[12]  N. Longo,et al.  Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: Lack of genotype–phenotype correlation , 2000, Human mutation.

[13]  P. Lundberg,et al.  Sex hormone-binding globulin--still many questions. , 1985, Scandinavian journal of clinical and laboratory investigation.

[14]  T. Hashimoto,et al.  Genomic DNA organization of human mitochondrial very-long-chain acyl-CoA dehydrogenase and mutation analysis. , 1995, Biochemical and biophysical research communications.

[15]  I Knudsen,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. , 2001, American journal of human genetics.

[16]  R. Wanders,et al.  SUDDEN INFANT DEATH AND LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE , 1989, The Lancet.

[17]  P. Waters,et al.  Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype. , 2000, Molecular Genetics and Metabolism.

[18]  L. Bolund,et al.  The role of chaperone-assisted folding and quality control in inborn errors of metabolism: Protein folding disorders , 2001, Journal of Inherited Metabolic Disease.

[19]  A. Yasui,et al.  DNA Repair Protein XPA Binds Replication Protein A (RPA) (*) , 1995, The Journal of Biological Chemistry.

[20]  B. Andresen,et al.  Very long chain acyl‐coenzyme A dehydrogenase deficiency with adult onset , 1998, Annals of neurology.

[21]  P. Divry,et al.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[22]  R. Vento,et al.  The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. , 1999, Cancer research.

[23]  A. Paetau,et al.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.

[24]  J. Moult,et al.  SNPs, protein structure, and disease , 2001, Human mutation.

[25]  N. Lehman,et al.  Early neonatal diagnosis of long-chain 3-hydroxyacyl coenzyme a dehydrogenase and mitochondrial trifunctional protein deficiencies. , 2002, Molecular genetics and metabolism.

[26]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[27]  P. Stenson,et al.  Human Gene Mutation Database—A biomedical information and research resource , 2000, Human mutation.

[28]  P. Clayton,et al.  Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. , 2001, The Journal of clinical investigation.

[29]  P. Bross,et al.  Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl‐CoA dehydrogenation deficiency , 2003, Human mutation.

[30]  L. D. Schroeder,et al.  Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. , 1999, American journal of human genetics.

[31]  T. Saijo,et al.  Isoalloxazine Ring of FAD Is Required for the Formation of the Core in the Hsp60-assisted Folding of Medium Chain Acyl-CoA Dehydrogenase Subunit into the Assembly Competent Conformation in Mitochondria (*) , 1995, The Journal of Biological Chemistry.

[32]  M. Culbertson,et al.  RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. , 1999, Trends in genetics : TIG.

[33]  C. Vianey‐Saban,et al.  Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. , 1993, Biochimica et biophysica acta.

[34]  L. Bolund,et al.  Effects of Two Mutations Detected in Medium Chain Acyl-CoA Dehydrogenase (MCAD)-deficient Patients on Folding, Oligomer Assembly, and Stability of MCAD Enzyme (*) , 1995, The Journal of Biological Chemistry.

[35]  J. Vockley,et al.  Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. , 2000, American journal of human genetics.

[36]  Crystal Structure of Rat Short Chain Acyl-CoA Dehydrogenase Complexed with Acetoacetyl-CoA , 2002, The Journal of Biological Chemistry.

[37]  M. Ugarte,et al.  Expression Analysis of Phenylketonuria Mutations , 2000, The Journal of Biological Chemistry.

[38]  B. Kerem,et al.  Splicing regulation as a potential genetic modifier. , 2002, Trends in genetics : TIG.

[39]  H. Pihko,et al.  Long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency , 1999, Acta paediatrica.

[40]  H. Dietz,et al.  Nonsense-mediated mRNA decay in health and disease. , 1999, Human molecular genetics.

[41]  D. Turnbull,et al.  Combined enzyme defect of mitochondrial fatty acid oxidation. , 1992, The Journal of clinical investigation.

[42]  P. Huttenlocher,et al.  Short chain fatty acid‐induced central hyperventilation in rabbits , 1978, Neurology.

[43]  P. Bross,et al.  Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations , 2000, European Journal of Pediatrics.

[44]  K. Tanaka,et al.  Impaired tetramer assembly of variant medium-chain acyl-coenzyme A dehydrogenase with a glutamate or aspartate substitution for lysine 304 causing instability of the protein. , 1992, The Journal of biological chemistry.

[45]  C. Stanley,et al.  Aberrant mRNA splicing associated with coding region mutations in children with carnitine-acylcarnitine translocase deficiency. , 2001, Molecular genetics and metabolism.

[46]  M. Bennett,et al.  Inborn Errors of Mitochondrial Fatty Acid Oxidation , 2000, Critical reviews in clinical laboratory sciences.

[47]  L. Bolund,et al.  Ethylmalonic Aciduria Is Associated with an Amino Acid Variant of Short Chain Acyl-Coenzyme A Dehydrogenase , 1996, Pediatric Research.

[48]  B. Andresen,et al.  Myopathy in very-long-chain acyl-CoA dehydrogenase deficiency: clinical and biochemical differences with the fatal cardiac phenotype , 1999, Neuromuscular Disorders.

[49]  K. Tanaka,et al.  Intramitochondrial folding and assembly of medium-chain acyl-CoA dehydrogenase (MCAD). Demonstration of impaired transfer of K304E-variant MCAD from its complex with hsp60 to the native tetramer. , 1994, Journal of Biological Chemistry.

[50]  J. Vockley,et al.  Defects of mitochondrial β-oxidation: a growing group of disorders , 2002, Neuromuscular Disorders.

[51]  B. Amendt,et al.  Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. , 1987, The Journal of clinical investigation.

[52]  J. Barnard,et al.  Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[53]  A. Engel,et al.  The syndrome of systemic carnitine deficiency , 1975, Neurology.

[54]  L. Bolund,et al.  Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E. coli , 1991, Human Genetics.

[55]  F. Suchy,et al.  A defect in the transport of long-chain fatty acids associated with acute liver failure. , 1998, The New England journal of medicine.

[56]  P. Bross,et al.  Impaired folding and subunit assembly as disease mechanism: the example of medium-chain acyl-CoA dehydrogenase deficiency. , 1998, Progress in nucleic acid research and molecular biology.

[57]  T. Hashimoto,et al.  Medium Chain 3-Ketoacyl-Coenzyme A Thiolase Deficiency: A New Disorder of Mitochondrial Fatty Acid β-Oxidation , 1997, Pediatric Research.

[58]  F. Hartl,et al.  Protein folding in mitochondria requires complex formation with hsp60 and ATP hydrolysis , 1989, Nature.

[59]  P. Bross,et al.  Biochemical characterization of purified, human recombinant Lys304-->Glu medium-chain acyl-CoA dehydrogenase containing the common disease-causing mutation and comparison with the normal enzyme. , 1997, European journal of biochemistry.

[60]  L. D. Schroeder,et al.  Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism. , 2000, American journal of human genetics.

[61]  L. Bolund,et al.  Comparison between medium‐chain acyl‐CoA dehydrogenase mutant proteins overexpressed in bacterial and mammalian cells , 1995, Human mutation.

[62]  L. Bolund,et al.  Protein misfolding and degradation in genetic diseases , 1999, Human mutation.

[63]  J. Saudubray,et al.  Carnitine palmitoyltransferase deficiencies. , 1999, Molecular genetics and metabolism.

[64]  P. Bougnères,et al.  Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. , 1981, The Journal of pediatrics.

[65]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[66]  J. Vockley,et al.  Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. , 2001, The Journal of pediatrics.

[67]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[68]  J. Gargus,et al.  Phenotype and genotype variation in primary carnitine deficiency , 2001, Genetics in Medicine.

[69]  D. Rabier,et al.  Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. , 1999, Circulation.

[70]  F. Hartl,et al.  Protein-catalysed protein folding. , 1990, Trends in biotechnology.

[71]  L. Bolund,et al.  Co-overexpression of bacterial GroESL chaperonins partly overcomes non-productive folding and tetramer assembly of E. coli-expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutation. , 1993, Biochimica et biophysica acta.

[72]  H. Bremer,et al.  Glutaric aciduria type II: report on a previously undescribed metabolic disorder. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[73]  L. Bolund,et al.  Misfolding, Degradation, and Aggregation of Variant Proteins , 2003, Journal of Biological Chemistry.

[74]  J. Vockley,et al.  Role of Common Gene Variations in the Molecular Pathogenesis of Short-Chain Acyl-CoA Dehydrogenase Deficiency , 2001, Pediatric Research.

[75]  C. Stanley,et al.  The structure and organization of the human carnitine/acylcarnitine translocase (CACT1) gene2. , 1998, Biochemical and biophysical research communications.

[76]  S. Dimauro,et al.  Short‐chain L‐3‐hydroxyacyl‐CoA dehydrogenase deficiency in muscle: A new cause for recurrent myoglobinuria and encephalopathy , 1991, Annals of neurology.

[77]  L. Bolund,et al.  Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl‐CoA dehydrogenase deficiencies, with special focus on genotype–phenotype relationship , 2001, Human mutation.

[78]  D. Kelly,et al.  Structural organization and regulatory regions of the human medium-chain acyl-CoA dehydrogenase gene. , 1992, Biochemistry.

[79]  D. Hale,et al.  Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. , 1995, Proceedings of the National Academy of Sciences of the United States of America.